代谢组学分析识别哮喘严重程度的不同代谢表型
该研究采用液相色谱-高分辨质谱代谢组学分析22名健康人和54名哮喘患者(12轻、20中、22重)的血清,确认了66种代谢物,其中15种在哮喘中显著改变。油酰乙醇胺随哮喘严重程度独立于类固醇治疗而升高(p<0.001),多变量分析显示轻症与对照、重症与其他组之间存在代谢差异,提示哮喘具有疾病严重程度依赖的轻度全身代谢偏移,且类固醇治疗显著影响代谢。
要点
- 哮喘患者血清代谢谱与健康人不同,且随严重程度变化。
- 油酰乙醇胺水平随哮喘严重程度升高,独立于类固醇治疗。
- 类固醇治疗显著影响脱氢表雄酮硫酸盐等代谢物水平。
核心结论
- 哮喘以疾病严重程度依赖的轻度全身代谢偏移为特征,类固醇治疗显著影响代谢。
研究设计与样本
- 研究纳入22名健康个体和54名哮喘患者(12名轻度、20名中度、22名重度),采用液相色谱-高分辨质谱代谢组学分析血清,并通过靶向质谱验证选定代谢物。
主要发现
- 共确认66种代谢物,其中15种在哮喘中显著改变(p≤0.05)。
- 脱氢表雄酮硫酸盐、可的松、皮质醇、脯氨酰羟脯氨酸、哌可酸和N-棕榈酰牛磺酸水平与吸入性糖皮质激素剂量显著相关(p<0.05),且在口服糖皮质激素治疗者中进一步偏移。
- 油酰乙醇胺随哮喘严重程度升高,独立于类固醇治疗(p<0.001)。
- 多变量分析显示对照与轻度哮喘患者间平均差异显著(p=0.025),重度哮喘与其他所有组间平均差异显著(p=1.7×10-4)。
- 轻度哮喘相对对照的代谢偏移与外源性代谢物(如膳食脂质)相关,而中重度哮喘的代谢偏移(如油酰乙醇胺、1-磷酸鞘氨醇、N-棕榈酰牛磺酸)推测涉及激活瞬时受体电位香草酸亚型1(TRPV1)受体。
临床怎么用
- 血清代谢组学可能有助于区分哮喘严重程度和评估类固醇治疗影响,油酰乙醇胺等代谢物或成为潜在生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this study, we sought to determine whether asthma has a metabolic profile and whether this profile is related to disease severity.We characterised the serum from 22 healthy individuals and 54 asthmatics (12 mild, 20 moderate, 22 severe) using liquid chromatography-high-resolution mass spectrometry-based metabolomics. Selected metabolites were confirmed by targeted mass spectrometry assays of eicosanoids, sphingolipids and free fatty acids.We conclusively identified 66 metabolites; 15 were significantly altered with asthma (p≤0.05). Levels of dehydroepiandrosterone sulfate, cortisone, cortisol, prolylhydroxyproline, pipecolate and N-palmitoyltaurine correlated significantly (p<0.05) with inhaled corticosteroid dose, and were further shifted in individuals treated with oral corticosteroids. Oleoylethanolamide increased with asthma severity independently of steroid treatment (p<0.001). Multivariate analysis revealed two patterns: 1) a mean difference between controls and patients with mild asthma (p=0.025), and 2) a mean difference between patients with severe asthma and all other groups (p=1.7×10-4). Metabolic shifts in mild asthma, relative to controls, were associated with exogenous metabolites (e.g. dietary lipids), while those in moderate and severe asthma (e.g. oleoylethanolamide, sphingosine-1-phosphate, N-palmitoyltaurine) were postulated to be involved in activating the transient receptor potential vanilloid type 1 (TRPV1) receptor, driving TRPV1-dependent pathogenesis in asthma.Our findings suggest that asthma is characterised by a modest systemic metabolic shift in a disease severity-dependent manner, and that steroid treatment significantly affects metabolism.
引用
- Reinke SN, Gallart-Ayala H, Gómez C, et al. Metabolomics analysis identifies different metabotypes of asthma severity. Eur Respir J. 2017. PMID: 28356371. doi:10.1183/13993003.01740-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。